Replies to post #124872 on Anavex Life Sciences Corp (AVXL)

[imho]

Is it possible that Biogen's in-vitro testing was positive but the in-vivo testing was not so great and thus AVXL eliminated MS from their pipeline. Before I'm attacked....I am long. I just like to explore other possibilities.

A member of the AVXL FB Group was messaged by Anavex Investor Relations that the MTA with Biogen is still active.

Well that is good news if true. In that case we can say in-vivo testing is inconclusive (if it was run at all) at this point, but I think saying "it-works" is a bit over the top. The mystery of the MS pipeline omission continues.

IMHO